• Helping to enhance sight

    Nicox develops novel pharmaceuticals and diagnostics that can help people to enhance their sight

    Read more
  • Excellence through partnerships

    Nicox builds its innovative ophthalmic pipeline by collaborating with leading partners who share our passion for excellence

    Read more
  • AdenoPlus®

    A point-of-care diagnostic test for the differential diagnosis of acute conjunctivitis

    Read more

Featured article

  1. Nicox convenes General Meeting to vote on Aciex acquisition on October 22, 2014

    Nicox S.A. (NYSE Euronext Paris: COX) has published a notice to convene an Ordinary and Extraordinary General Meeting (EGM) on Wednesday, October 22, 2014,…[Read more]